TableĀ 2.

Indication for Transplantation by Treatment Group

ControlNitroprusside
GroupGroup
Recipient Pathologyn=24n=22
Cystic fibrosis7 (29.2)8 (36.4)
Chronic obstructive pulmonary disease2 (8.3)0
Eisenmenger syndrome01 (4.5)
Emphysema8 (33.3)5 (22.7)
Idiopathic pulmonary fibrosis4 (16.7)6 (27.3)
Bronchiolitis obliterans1 (4.2)2 (9.1)
Sarcoidosis2 (8.3)0
  • Notes: Data are presented as n (%). P>0.05 for each comparison.